Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Regenerative Medicine Essentials
    • World Stem Cell Summit
    • Exploring Public Policy: Regenerative Medicine and Cell Therapies
    • Congressional Briefings
    • Regenerative Medicine and Stem Cell Action Awards
    • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership – Register for WSCS and RME Course
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page
Clinical Trial Results Buoy Hope for Spinal Cord Injury Patients

Clinical Trial Results Buoy Hope for Spinal Cord Injury Patients

by Bernard Siegel | Mar 16, 2017 | News & Opinions, Science

The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine,has announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord. The...

Recent Posts

  • Human mesenchymal stem cells show promise in treating chronic lung infections
  • Longeveron Selected to Present at the 2021 World Stem Cell Summit Dr. Joshua Hare, Longeveron’s Chief Science Officer, to present during this year’s Longevity Session
  • Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury
  • Advancing the Development of Safe and Effective Regenerative Medicine Products
  • Clinical trial assesses stem cells’ ability to prevent major cause of preemie deaths
Tweets about @WSCSummit
CC Regenerative Medicine Foundation